The New Era of Postoperative Inflammation Management - Takeaway - MDSpire
Feature

The New Era of Postoperative Inflammation Management

What surgeons need to know about managing post-cataract inflammation

Share

  • 1

    Management of post-cataract inflammation is critical.

  • 2

    Corticosteroids inhibit inflammation early.

  • 3

    Adherence to topical drops is low (30%-80%).

  • 4

    Dexamethasone inserts reduce postoperative complexity.

  • 5

    NSAIDs can be used once or twice daily for added efficiency.

  • 6

    Glaucoma patients are at higher risk for cystoid macular edema.

  • 7

    Innovative delivery methods are emerging in ophthalmology.

  • 8

    Familiarity with billing codes for new therapies is essential.

Original Source(s)

The New Era of Postoperative Inflammation Management

  • by Nandini Venkateswaran (1)

  • April 30, 2026

Related Content

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

  • April 30, 2026

  • 3 min
Why Smart Eye Surgeons Still Make Bad Growth Decisions

You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey

Optogenetic RP Therapy Gains RMAT

Ray Therapeutics secures FDA RMAT designation for its optogenetic retinitis pigmentosa therapy

  • April 29, 2026

  • 2 min